Literature DB >> 29650663

Bystander risk, social value, and ethics of human research.

S K Shah1, J Kimmelman2, A D Lyerly3, H F Lynch4, F G Miller5, R Palacios6, C A Pardo7, C Zorrilla8.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29650663     DOI： 10.1126/science.aaq0917

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  15 in total

Review 1.  Regulating impact on bystanders in clinical trials: An unsettled frontier.

Authors:  Nir Eyal; Jonathan Kimmelman; Lisa G Holtzman; Marc Lipsitch
Journal:  Clin Trials       Date:  2019-08-01       Impact factor: 2.486

2.  Opinion: Risk to study nonparticipants: A procedural approach.

Authors:  Nir Eyal; Marc Lipsitch; Till Bärnighausen; Dan Wikler
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-07       Impact factor: 11.205

3.  Standards of evidence for institutional review board decision-making.

Authors:  David B Resnik
Journal:  Account Res       Date:  2020-12-08       Impact factor: 3.057

4.  Ethical and Practical Issues Associated With the Possibility of Using Controlled Human Infection Trials in Developing a Hepatitis C Virus Vaccine.

Authors:  Andrea Cox; Mark Sulkowski; Jeremy Sugarman
Journal:  Clin Infect Dis       Date:  2020-12-31       Impact factor: 20.999

Review 5.  Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy.

Authors:  Euzebiusz Jamrozik; Michael J Selgelid
Journal:  J Med Ethics       Date:  2020-05-07       Impact factor: 2.903

6.  How to Address the Risk of HIV Transmission in Remission Studies With Treatment Interruption: The Low-Hanging Fruit Approach.

Authors:  Nir Eyal
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

7.  Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A Symposium.

Authors:  Nir Eyal; Steven G Deeks
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

Review 8.  Zika Vaccine Development-Current Progress and Challenges for the Future.

Authors:  Joel N Maslow
Journal:  Trop Med Infect Dis       Date:  2019-07-14

9.  Conducting human challenge studies in LMICs: A survey of researchers and ethics committee members in Thailand.

Authors:  Jaranit Kaewkungwal; Pornpimon Adams; Jetsumon Sattabongkot; Reidar K Lie; David Wendler
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

Review 10.  Ethical issues in HIV remission trials.

Authors:  Nir Eyal; Lisa G Holtzman; Steven G Deeks
Journal:  Curr Opin HIV AIDS       Date:  2018-09       Impact factor: 4.283
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.